BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19642095)

  • 1. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia.
    Kim YT; Lee JM; Hur SY; Cho CH; Kim YT; Kim SC; Kang SB
    Int J Cancer; 2010 Apr; 126(8):1903-1909. PubMed ID: 19642095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
    Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
    Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
    Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY; Feng YK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
    Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
    JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
    Bogani G; DI Donato V; Sopracordevole F; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'Ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Tinelli R; DE Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Dessole S; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
    Gynecol Oncol; 2020 Dec; 159(3):636-641. PubMed ID: 32893030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
    Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
    Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
    Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
    Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
    Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
    Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
    Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
    Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
    Park JY; Lee KH; Dong SM; Kang S; Park SY; Seo SS
    Gynecol Oncol; 2008 Mar; 108(3):549-54. PubMed ID: 18177929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model.
    Fuste P; Bellosillo B; Santamaria X; Mancebo G; Mariñoso L; Alameda F; Espinet B; Sole F; Serrano S; Carreras R
    Int J Gynecol Pathol; 2009 Mar; 28(2):120-6. PubMed ID: 19188824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.
    Prato B; Ghelardi A; Gadducci A; Marchetti I; Di Cristofano C; Di Coscio G; Bevilacqua G; Genazzani AR
    Int J Gynecol Cancer; 2008; 18(1):90-4. PubMed ID: 17506849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
    Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
    Ruano Y; Torrents M; Ferrer FJ
    Eur J Gynaecol Oncol; 2015; 36(3):245-51. PubMed ID: 26189247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
    Nagai Y; Maehama T; Asato T; Kanazawa K
    Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.